Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Pacific Health Care Organization (PFHO) Gains from Investment Securities (2016 - 2024)

Historic Gains from Investment Securities for Pacific Health Care Organization (PFHO) over the last 13 years, with Q1 2024 value amounting to $46890.0.

  • Pacific Health Care Organization's Gains from Investment Securities rose 1381.62% to $46890.0 in Q1 2024 from the same period last year, while for Mar 2025 it was $8.9 million, marking a year-over-year increase of 1413556.07%. This contributed to the annual value of $56489.0 for FY2023, which is 746.91% up from last year.
  • Latest data reveals that Pacific Health Care Organization reported Gains from Investment Securities of $46890.0 as of Q1 2024, which was up 1381.62% from $8.8 million recorded in Q4 2023.
  • In the past 5 years, Pacific Health Care Organization's Gains from Investment Securities ranged from a high of $8.8 million in Q4 2023 and a low of -$8.8 million during Q2 2023
  • Over the past 3 years, Pacific Health Care Organization's median Gains from Investment Securities value was $46890.0 (recorded in 2024), while the average stood at $31188.4.
  • Per our database at Business Quant, Pacific Health Care Organization's Gains from Investment Securities skyrocketed by 1665118.24% in 2023 and then surged by 1381.62% in 2024.
  • Quarter analysis of 3 years shows Pacific Health Care Organization's Gains from Investment Securities stood at $52563.0 in 2022, then soared by 16651.18% to $8.8 million in 2023, then tumbled by 99.47% to $46890.0 in 2024.
  • Its Gains from Investment Securities stands at $46890.0 for Q1 2024, versus $8.8 million for Q4 2023 and -$8.8 million for Q2 2023.